Minoru Seto

3.2k total citations
53 papers, 2.8k citations indexed

About

Minoru Seto is a scholar working on Molecular Biology, Physiology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Minoru Seto has authored 53 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 18 papers in Physiology and 16 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Minoru Seto's work include Protein Kinase Regulation and GTPase Signaling (20 papers), Nitric Oxide and Endothelin Effects (16 papers) and Cardiomyopathy and Myosin Studies (12 papers). Minoru Seto is often cited by papers focused on Protein Kinase Regulation and GTPase Signaling (20 papers), Nitric Oxide and Endothelin Effects (16 papers) and Cardiomyopathy and Myosin Studies (12 papers). Minoru Seto collaborates with scholars based in Japan, United States and Germany. Minoru Seto's co-authors include Yasuharu Sasaki, James K. Liao, Kensuke Noma, Yoh Takuwa, Toshio Asano, Kazuo Yano, Masato Shibuya, Katsuhiko Sakurada, Shunsaku Hirai and Hiromitsu Nagumo and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and Circulation Research.

In The Last Decade

Minoru Seto

53 papers receiving 2.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Minoru Seto Japan 27 1.5k 666 454 366 328 53 2.8k
Joseph A. Erhardt United States 25 1.3k 0.9× 404 0.6× 204 0.4× 457 1.2× 291 0.9× 32 2.6k
Antonio Feliciello Italy 37 2.4k 1.6× 351 0.5× 330 0.7× 508 1.4× 305 0.9× 67 3.5k
Kousuke Noda Japan 41 2.2k 1.4× 375 0.6× 499 1.1× 192 0.5× 200 0.6× 168 5.2k
Brian T. Scott United States 27 1.7k 1.1× 655 1.0× 499 1.1× 261 0.7× 199 0.6× 40 3.0k
Che-Hong Chen United States 17 1.5k 1.0× 475 0.7× 534 1.2× 290 0.8× 231 0.7× 18 2.7k
Marie‐Hélène Disatnik United States 28 2.8k 1.9× 715 1.1× 575 1.3× 369 1.0× 505 1.5× 42 3.9k
Natalia A. Riobo‐Del Galdo United States 31 3.2k 2.1× 884 1.3× 155 0.3× 300 0.8× 228 0.7× 64 4.3k
Alessandro Alessandrini United States 32 2.7k 1.8× 322 0.5× 263 0.6× 511 1.4× 398 1.2× 56 4.6k
David J. Mancuso United States 31 1.9k 1.2× 782 1.2× 258 0.6× 161 0.4× 435 1.3× 39 3.1k
Xinli Hu China 35 2.3k 1.5× 628 0.9× 686 1.5× 253 0.7× 182 0.6× 88 3.7k

Countries citing papers authored by Minoru Seto

Since Specialization
Citations

This map shows the geographic impact of Minoru Seto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Minoru Seto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Minoru Seto more than expected).

Fields of papers citing papers by Minoru Seto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Minoru Seto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Minoru Seto. The network helps show where Minoru Seto may publish in the future.

Co-authorship network of co-authors of Minoru Seto

This figure shows the co-authorship network connecting the top 25 collaborators of Minoru Seto. A scholar is included among the top collaborators of Minoru Seto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Minoru Seto. Minoru Seto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Seto, Minoru & Toshio Asano. (2011). Rho-kinase inhibitors. Folia Pharmacologica Japonica. 138(3). 112–116. 1 indexed citations
2.
Rashid, Mamunur, Shunsuke Tawara, Yoshihiro Fukumoto, et al.. (2009). Importance of Rac1 Signaling Pathway Inhibition in the Pleiotropic Effects of HMG-CoA Reductase Inhibitors(Vascular Medicine). Japanese Circulation Journal-english Edition. 73(2). 361–370. 10 indexed citations
3.
Kawasaki, Koh, Kazuo Yano, Shunsuke Tawara, et al.. (2009). Correspondence Between Neurological Deficit, Cerebral Infarct Size, and Rho-Kinase Activity in a Rat Cerebral Thrombosis Model. Journal of Molecular Neuroscience. 39(1-2). 59–68. 12 indexed citations
4.
Liao, James K., Minoru Seto, & Kensuke Noma. (2007). Rho Kinase (ROCK) Inhibitors. Journal of Cardiovascular Pharmacology. 50(1). 17–24. 343 indexed citations
5.
Nishio, Yutaka, Masao Koda, Keiko Kitajo, et al.. (2006). Delayed treatment with Rho-kinase inhibitor does not enhance axonal regeneration or functional recovery after spinal cord injury in rats. Experimental Neurology. 200(2). 392–397. 40 indexed citations
6.
Shibuya, Masato, et al.. (2005). Effects of fasudil in acute ischemic stroke: Results of a prospective placebo-controlled double-blind trial. Journal of the Neurological Sciences. 238(1-2). 31–39. 238 indexed citations
7.
Shiraishi, Mitsuya, et al.. (2004). Inhibition of protein kinase C-mediated contraction by Rho kinase inhibitor fasudil in rabbit aorta. Naunyn-Schmiedeberg s Archives of Pharmacology. 370(5). 414–422. 8 indexed citations
8.
Ozaki, Hiroshi, Katsuhiko Yasuda, Hideharu Kanzaki, et al.. (2003). Possible role of the protein kinase C/CPI‐17 pathway in the augmented contraction of human myometrium after gestation. British Journal of Pharmacology. 140(7). 1303–1312. 58 indexed citations
9.
Nagumo, Hiromitsu, Yasuharu Sasaki, Yoshitaka Ono, et al.. (2000). Rho kinase inhibitor HA-1077 prevents Rho-mediated myosin phosphatase inhibition in smooth muscle cells. American Journal of Physiology-Cell Physiology. 278(1). C57–C65. 184 indexed citations
10.
Kishi, Hiroko, Takashi Mikawa, Minoru Seto, et al.. (2000). Stable Transfectants of Smooth Muscle Cell Line Lacking the Expression of Myosin Light Chain Kinase and Their Characterization with Respect to the Actomyosin System. Journal of Biological Chemistry. 275(2). 1414–1420. 33 indexed citations
11.
Seto, Minoru, Yoh Takuwa, & Yasuharu Sasaki. (1999). The Molecular mechanism of vasospasm and the attenuation by fasudil. Folia Pharmacologica Japonica. 114(supplement). 66–70. 8 indexed citations
12.
Asano, Toshio, Ichiro Ikegaki, Shin’ichi Satoh, Minoru Seto, & Yasuharu Sasaki. (1998). A Protein Kinase Inhibitor, Fasudil (AT‐877): A Novel Approach to Signal Transduction Therapy. Cardiovascular Drug Reviews. 16(1). 76–87. 21 indexed citations
13.
Nagumo, Hiromitsu, Minoru Seto, Katsuhiko Sakurada, Michael Walsh, & Yasuharu Sasaki. (1998). HA1077, a protein kinase inhibitor, inhibits calponin phosphorylation on Ser175 in porcine coronary artery. European Journal of Pharmacology. 360(2-3). 257–264. 16 indexed citations
14.
Watanabe, Hiroshi, Reiko Takahashi, Xuxia Zhang, et al.. (1998). An essential role of myosin light‐chain kinase in the regulation of agonist‐ and fluid flow‐stimulated Ca 2+ influx in endothelial cells. The FASEB Journal. 12(3). 341–348. 76 indexed citations
15.
Seto, Minoru, et al.. (1995). Selectivity of action of staurosporine on Ca2+ movements and contractions in vascular smooth muscles. European Journal of Pharmacology. 294(2-3). 693–701. 13 indexed citations
16.
Seto, Minoru, Kazutoshi Shindo, Kei Ito, & Yasuharu Sasaki. (1995). Selective inhibition of myosin phosphorylation and tension of hyperplastic arteries by the kinase inhibitor HA1077. European Journal of Pharmacology. 276(1-2). 27–33. 23 indexed citations
17.
Harada, Tsutomu, Minoru Seto, Yasuharu Sasaki, et al.. (1995). The Time Course of Myosin Light-Chain Phosphorylation in Blood-induced Vasospasm. Neurosurgery. 36(6). 1178–1183. 32 indexed citations
18.
Ishida, Makoto, et al.. (1993). Str and its derivatives inhibited MLC20 phosphorylation_ in platelet.. The Japanese Journal of Pharmacology. 61. 207–207. 1 indexed citations
19.
Seto, Minoru, Kazuo Yano, Yasuharu Sasaki, & Hiroshi Azuma. (1993). Intimal Hyperplasia Enhances Myosin Phosphorylation in Rabbit Carotid Artery. Experimental and Molecular Pathology. 58(1). 1–13. 25 indexed citations
20.
Seto, Minoru, et al.. (1991). Effects of HA1077, a protein kinase inhibitor, on myosin phosphorylation and tension in smooth muscle. European Journal of Pharmacology. 195(2). 267–272. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Joseph A. Erhardt Breakdown of academic impact, for papers by Antonio Feliciello Breakdown of academic impact, for papers by Kousuke Noda Breakdown of academic impact, for papers by Brian T. Scott Breakdown of academic impact, for papers by Che-Hong Chen Breakdown of academic impact, for papers by Marie‐Hélène Disatnik Breakdown of academic impact, for papers by Natalia A. Riobo‐Del Galdo Breakdown of academic impact, for papers by Alessandro Alessandrini Breakdown of academic impact, for papers by David J. Mancuso Breakdown of academic impact, for papers by Xinli Hu
Rankless by CCL
2026